Vista Pharmaceuticals Ltd — Important, 15-07-2026: Company Update

Vista Pharmaceuticals Limited announced it has completed its share dematerialization process for the quarter ended June 30, 2026. The company certified that all securities received for dematerialization were properly verified, mutilated, and cancelled. Crucially, the depository's name was updated as the registered owner in company records in a timely manner. The dematerialized shares continue to be listed on the same stock exchanges as the company's existing securities, ensuring transparency and proper governance for investors.